Jill Dreyfus is Senior Director of Evidence Generation. Jill is responsible for generating high-quality evidence across the NEST collaborative network and to facilitate the design and implementation of studies to address the needs of medical device stakeholders. In the near term, she will be focusing on the NESTcc Mark and overseeing implementation project work while supporting the development of the NESTcc Medical Device Real World Evidence Marketplace, and the NESTcc “Data” Window initiatives.
Jill has over 25 years of experience in research that has spanned across the healthcare industry, including at pharmaceutical and consulting companies, hospitals, an academic center, and a contract research organization. Most recently, she worked on safety studies and regulatory reporting for Vaccine and Hospital products at Pfizer. Prior experience includes scientific and administrative oversight for health outcomes, cost, and burden of disease studies utilizing real-world data for medical device and other healthcare clients at Premier, Inc. and at Avalere Health/Inovalon, as well as epidemiology forecasting at Decision Resources (now Clarivate). She has expertise in using hospital discharge, commercial claims, Medicare, and electronic health record (EHR) data to answer research questions across a variety of therapeutic areas. Jill holds a PhD in Epidemiology from the University of Minnesota and an MPH in Epidemiology and Biostatistics from Boston University.
